高通量透析对藏族患者高血压控制及耐受性观察

目的观察高通量血液透析对藏族终末期肾病患者顽固性高血压的控制效果及患者对该治疗的耐受性。方法将同一时期在我院治疗的29例终末期肾病合并顽固性高血压的藏族患者分为研究组（高通量血液透析组）16例,对照组（普通血液透析）13例,分别观察患者接受不同透析方式治疗前及治疗12周后的血压水平,同时对比观察两种治疗过程中不良反应的发生率。结果两组患者治疗前血压水平差异无统计学意义（P〉0.05）,治疗12周后两组差异有统计学意义（P〈0.05）,两组治疗过程中不良反应发生率差异无统计学意义（P〉0.05）。结论高通量血液透析对藏族终末期肾病患者的血压控制疗效比普通血液透析优越,耐受性良好。

An Observation of Hypertension Control and Tolerance in Tibetan Patients with High-flux Hemodialysis.

Objective To observe the effects of hypertension control in Tibetan ESRD （end-stage renal disease）patients with high-flux hemodialysis and the tolerance of this treatment. Methods 29 cases of Tibetan ESRD patients who were receiving hemodialysis during the same period in our hospital were divided into study group （high-flux hemodialysis group）with 16 cases and control group（ common hemodialysis group）with 13 cases. To observe the the blood pressure before and 12 weeks after the treatment, as well as the incidence of adverse reactions in each group at the same time. Results There is no significant difference in blood pressure between the two groups before treatment（P 〉 0. 05 ）, while, there is significant difference between the two groups after the treatment（P 〈0. 05）. And there is no significant difference in adverse reactions between the two groups during the treatment （P 〉 0. 05 ）. Conclusion High-flux hemodialysis has a final positive curative effect and good tolerence in Tibetan ESRD patients.